MEDICLIN AG — Earnings Release 2007

May 10, 2007

News Details

Corporate | 10 May 2007 10:19

MediClin is satisfied with the development of the first quarter of 2007

MediClin AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Frankfurt, May 10, 2007 – In the first quarter of the 2007 financial year
MEDICLIN Aktiengesellschaft (MediClin) was able to further increase sales
as compared to the same quarter last year. With sales of EUR 94.7 mill. it
is 3.3 % above the previous year's value of EUR 91.8 mill. Despite a
substantial rise in costs the operating result of the Group rose by just
under 38 % or EUR 0.4 mill. to EUR 1.5 mill. as a result of increased
sales. The result attributable to shareholders is positive amounting EUR
0.2 mill.. In the previous year the compa¬rable figure was EUR -0.4 mill.

Materials expense rose considerable as compared to the same quarter in the
pervious year, in particular in the area of energy costs and due to
increase in VAT. Staff costs were on the same level as in the first quarter
of 2006.

Segment development
Sales in all three segments rose as compared to the first quarter of 2006.
In the post-acute segment, increased sales and the effects of the measures
introduced led to a further profit improvement. In the acute segment,
despite increased sales, the result was slightly less than the previous
year’s value for the same quarter, due to the well-known restrictions
resulting from the health care system reform. The nursing care segment
attained a result which is on par with the figure for the same period last
year.

Number of nursing days and cases increased
The number of nursing days provided in the Group rose by 13,662 days to
539,172, the number of cases by 459 to 26,245 as compared to the same
quarter in the previous year.
The share of outpatient health care in the Group revenue totalled EUR 2.2
mill. (Q1 2006: EUR 2.0 mill.).
The interim report as of March 31, 2007 is available on www.mediclin.de.

Key figures - year on year comparison Group
in million Euro Q1 2007 Q1 2006
Sales revenues 94.7 91.8
Cost of materials 20.9 19.2
Personnel expenses 54.6 54.3
Depreciation 2.1 2.0
Other operating expenses 17.0 16.4
Operating result 1.5 1.1
Consolidated net profit/net loss 0.2 -0.4
Cashflow from operating activities 0.6 -0.3
Earnings per share in Euro 0.00 -0.01
Number of employees
(in full time staff, quarterly average) 5,230 5,223

About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 30
clinics and 8 nursing care facilities and 3 Medizinische Versorgungszentren
(medical care units) in 11 federal states MediClin has a total capacity of
approximately 7,400 beds. MediClin’s facilities include acute care clinics,
i.e., general hospitals, special treatment facilities, specialised
hospitals and clinics for post-acute treatment and medical rehabilitation.
MediClin has approximately 6,900 employees.

Important notice:
This press release includes future-oriented statements which are based on
assumptions and estimates. While MediClin AG is of the opinion that these
assumptions and estimates are correct, the actual future developments and
actual future results may deviate from these assumptions and estimates due
to the impact of various factors such as changes in the economic conditions
in Germany, legal changes concerning the health system, changes relating to
cost providers’ expense behaviour. MediClin does not assume liability and
gives no warranty that future developments and the income actually achieved
in the future will comply with the assumptions and estimates stated in this
press release.

DGAP 10.05.2007

Language: English
Issuer: MediClin AG
Wilhelm-Leuschner-Straße 9-11
60329 Frankfurt am Main Deutschland
Phone: +49 (0)69 25 60 02-0
Fax: +49 (0)69 25 60 02-69
E-mail: ute.brauer@mediclin.de
www: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin-Bremen, Düsseldorf, Hamburg, Stuttgart

End of News DGAP News-Service

---